Neck numbing injection could cut painkiller use after surgery
NCT ID NCT07236086
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will test whether a superficial cervical plexus block, a numbing injection near certain neck nerves, can reduce pain after maxillofacial surgeries like abscess drainage or lymph node biopsies. Seventy adults aged 18-65 will be randomly assigned to receive the block or standard care. Researchers will measure how long it takes before patients need extra pain relief and how much pain they report.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- superficial cervical plexus nerve block (a numbing injection near the neck nerves)
- What this could lead to
- If it works, this could offer a simple, drug-sparing way to manage pain after certain face and neck surgeries, reducing the need for strong painkillers.
- What could go wrong
- This is a small, early-stage study with only 70 participants. The block may not provide better pain relief than standard care, and there are risks like infection, bleeding, or accidental injection into a blood vessel.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 70 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jan 2026
An estimate. Start dates often move.
- Expected to finish
-
Apr 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * • Age 18-65 years * BMI \< 30 kg/m2 * American Society of Anesthesiologists physical status classification (ASA) I - III * Patients scheduled for maxillofacial procedures involving submandibular area e.g. submandibular and submental abscesses, neck region e.g. cervical lymph node biopsies and ear lobe procedures. Exclusion Criteria: * • Patient refusal * Coagulopathy * Local infection ate the site of injection * Pre-existing neuropathy or neurological disease * Hypersensitivity to local anaesthetics used
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Maxillofacial surgeries are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.